Log In
Print
BCIQ
Print
Print this Print this
 

AEZS-120

  Manage Alerts
Collapse Summary General Information
Company Aeterna Zentaris Inc.
DescriptionLive, recombinant Salmonella typhi Ty21a-based oral vaccine expressing prostate-specific antigen (KLK3; PSA fused to the B subunit of cholera toxin
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationProstate cancer
Indication DetailsTreat prostate cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today